Analysis of the Western European Next Generation Sequencing (NGS) Market

Analysis of the Western European Next Generation Sequencing (NGS) Market

Clinical Applications Grow, Regulations Stiffen, Acquisitions Mount

RELEASE DATE
11-Jun-2014
REGION
Global
Deliverable Type
Market Research
Research Code: MA03-01-00-00-00
SKU: LS00098-GL-MR_16939
AvailableYesPDF Download

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
LS00098-GL-MR_16939

$4,950.00

$3,712.50save 25 %

DownloadLink
ENQUIRE NOW

Description

This study explores Western Europe’s dynamic next generation sequencing (NGS) market. The majority of the quantitative and qualitative information was acquired through primary research conducted with NGS providers. The market is broadly classified into 2 major segments: instruments and reagents, and 2 subsegments: research use only and clinical diagnostic use. Geographic segmentation covers the United Kingdom, Germany, France, Spain, Italy, Benelux, and Scandinavia. Also, the study includes a competitive analysis (SWOT), product analysis, revenue forecasts, and market share using a base year of 2013 and a 2014–2018 forecast period. A list of key sequencing service providers for each country or region is included.

Table of Contents

Key Findings

Key Findings (continued)

Scope and Segmentation

Key Questions This Study Will Answer

Market Engineering Measurements

CEO’s Perspective

Key Companies to Watch

Executive Summary—3 Big Predictions

Market Definitions

Evolution of Molecular Genetic Testing

DNA Testing Ecosystem—Where Does NGS Fit?

Market Age

Market Segmentation

Western European Market Perspective

Defining Healthcare Trends in the Future

Procurement Process

New Market Opportunities

New Market Opportunities (continued)

New Market Opportunities (continued)

Merger, Acquisition, and Partnership Assessment

Merger, Acquisition, and Partnership Assessment (continued)

Merger, Acquisition, and Partnership Assessment (continued)

Merger, Acquisition, and Partnership Assessment (continued)

Merger, Acquisition, and Partnership Assessment (continued)

Market Drivers

Market Restraints

Market Impact of Top 8 Trends

Market Engineering Measurements

Forecast Assumptions and Definitions

Revenue Forecast

Percent Revenue Forecast by Product Type

Revenue Forecast by Product Type

Revenue Forecast Discussion

Revenue Forecast Discussion (continued)

Installed Base by Country

Number of Facilities

Market Outlook in Western Europe

Percent Revenue Forecast by Reagent Segment

Revenue Forecast by Reagent Segment

Revenue Forecast Discussion

Revenue Forecast Discussion (continued)

Western European NGS Instruments—Market Share

Western European NGS Instruments—Market Share Analysis

Western European NGS Instruments—Market Share Analysis (continued)

Western European NGS Instruments—Market Share Analysis (continued)

Illumina—Overview

Product Analysis—Illumina

Applications

Life Technologies—Overview

Product Analysis—Life Technologies

Applications

Roche (454 Life Sciences)—Overview

Product Analysis—Roche

Applications

Pacific Biosciences—Overview

Product Analysis—Pacific Biosciences

Applications

Top Competitors

Top Competitors (continued)

Top Competitors (continued)

Top Competitors (continued)

Market Analysis

Western Europe Key Findings

PEST Analysis

Percent Sales Breakdown by Country

UK—Revenue Forecast

Revenue Forecast Discussion

NGS Instruments—Service Providers

NGS Instruments—Service Providers (continued)

NGS Instruments—Service Providers (continued)

NGS Instruments—Service Providers (continued)

Germany—Revenue Forecast

Revenue Forecast Discussion

NGS Instruments—Service Providers

NGS Instruments—Service Providers (continued)

NGS Instruments—Service Providers (continued)

NGS Instruments—Service Providers (continued)

France—Revenue Forecast

Revenue Forecast Discussion

NGS Instruments—Service Providers

NGS Instruments—Service Providers (continued)

NGS Instruments—Service Providers (continued)

Spain—Revenue Forecast

Revenue Forecast Discussion

NGS Instruments—Service Providers

NGS Instruments—Service Providers (continued)

NGS Instruments—Service Providers (continued)

NGS Instruments—Service Providers (continued)

Italy—Revenue Forecast

Revenue Forecast Discussion

NGS Instruments—Service Providers

NGS Instruments—Service Providers (continued)

Benelux—Revenue Forecast

Revenue Forecast Discussion

Revenue Forecast Discussion (continued)

Revenue Forecast Discussion (continued)

NGS Instruments—Service Providers

NGS Instruments—Service Providers (continued)

NGS Instruments—Service Providers (continued)

Scandinavia—Revenue Forecast

Revenue Forecast Discussion

Revenue Forecast Discussion (continued)

NGS Instruments—Service Providers

NGS Instruments—Service Providers (continued)

NGS Instruments—Service Providers (continued)

The Last Word—3 Big Predictions

The Last Word—Discussion

The Last Word—Discussion (continued)

The Last Word—Discussion (continued)

The Last Word—Discussion (continued)

Legal Disclaimer

List of Commercial Providers for Genetic Tests

List of Commercial Providers for Genetic Tests (continued)

List of Commercial Providers for Genetic Tests (continued)

Drivers Explained

Drivers Explained (continued)

Drivers Explained (continued)

Drivers Explained (continued)

Drivers Explained (continued)

Drivers Explained (continued)

Restraints Explained

Restraints Explained (continued)

Restraints Explained (continued)

Restraints Explained (continued)

Restraints Explained (continued)

Additional Sources of Information

Market Engineering Methodology

Learn More—Next Steps

This research service focuses on antiviral/antiretroviral therapeutics for the treatment of HIV/AIDS. A product and pipeline assessment is provided for marketed and investigational products and combination regimens for the treatment of HIV infection. Segmentation by drug class is provided along with additional supporting information such as clinical trial timelines and results, historical and projected launch timelines, and global prevalence by region and country. Key market developments since Q1 2013 and key companies to watch are also included. This research service is an update of the 2013 research service titled Strategic Analysis of Antiviral Drug Development for Viral Hepatitis and HIV/AIDS.
More Information
Deliverable Type Market Research
No Index No
Podcast No
Author Divyaa Ravishankar
WIP Number MA03-01-00-00-00
Is Prebook No